Page last updated: 2024-10-06

Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C)

Proteins (0)

Compounds (1)

CompoundDescription
cytarabineA pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)